PetMed Express, Inc.
PETS
$2.46
$0.031.24%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 40.66M | 44.36M | 51.18M | 46.47M | 51.96M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 40.66M | 44.36M | 51.18M | 46.47M | 51.96M |
| Cost of Revenue | 31.20M | 31.95M | 36.78M | 27.52M | 35.83M |
| Gross Profit | 9.46M | 12.42M | 14.40M | 18.95M | 16.13M |
| SG&A Expenses | 17.52M | 17.29M | 18.90M | 30.83M | 14.79M |
| Depreciation & Amortization | 2.40M | 2.28M | 2.28M | 2.07M | 1.59M |
| Other Operating Expenses | -- | -- | -- | -1.18M | -- |
| Total Operating Expenses | 51.12M | 51.52M | 57.96M | 59.25M | 52.20M |
| Operating Income | -10.46M | -7.16M | -6.78M | -12.78M | -241.00K |
| Income Before Tax | -10.54M | -8.51M | -34.14M | -5.98M | -242.00K |
| Income Tax Expenses | 11.00K | 9.00K | 9.00K | 5.66M | 465.00K |
| Earnings from Continuing Operations | -10.55M | -8.52M | -34.15M | -11.64M | -707.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.55M | -8.52M | -34.15M | -11.64M | -707.00K |
| EBIT | -10.46M | -7.16M | -6.78M | -12.78M | -241.00K |
| EBITDA | -8.06M | -4.88M | -4.50M | -10.71M | 1.35M |
| EPS Basic | -0.50 | -0.41 | -1.65 | -0.56 | -0.03 |
| Normalized Basic EPS | -0.31 | -0.22 | -0.20 | -0.39 | 0.00 |
| EPS Diluted | -0.50 | -0.41 | -1.65 | -0.56 | -0.03 |
| Normalized Diluted EPS | -0.31 | -0.22 | -0.20 | -0.39 | 0.00 |
| Average Basic Shares Outstanding | 21.01M | 20.89M | 20.76M | 20.64M | 20.63M |
| Average Diluted Shares Outstanding | 21.01M | 20.89M | 20.76M | 20.64M | 20.63M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -0.01% | -0.26% | 0.00% | -0.04% | -0.14% |